These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 12706957)

  • 1. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.
    Manji HK; Quiroz JA; Sporn J; Payne JL; Denicoff K; A Gray N; Zarate CA; Charney DS
    Biol Psychiatry; 2003 Apr; 53(8):707-42. PubMed ID: 12706957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system.
    Zarate CA; Du J; Quiroz J; Gray NA; Denicoff KD; Singh J; Charney DS; Manji HK
    Ann N Y Acad Sci; 2003 Nov; 1003():273-91. PubMed ID: 14684452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder.
    Zarate CA; Singh J; Manji HK
    Biol Psychiatry; 2006 Jun; 59(11):1006-20. PubMed ID: 16487491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Novel Treatments for Severe Mood Disorders Involving Cellular Plasticity Cascades.
    Machado-Vieira R; Zarate CA; Manji HK
    Curr Psychos Ther Rep; 2006 Dec; 4(4):181-190. PubMed ID: 25620894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
    Manji HK; Duman RS
    Psychopharmacol Bull; 2001; 35(2):5-49. PubMed ID: 12397885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.
    Gray NA; Zhou R; Du J; Moore GJ; Manji HK
    J Clin Psychiatry; 2003; 64 Suppl 5():3-17. PubMed ID: 12720479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of depression: the concept of synaptic plasticity.
    Duman RS
    Eur Psychiatry; 2002 Jul; 17 Suppl 3():306-10. PubMed ID: 15177086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders.
    Quiroz JA; Manji HK
    Dialogues Clin Neurosci; 2002 Mar; 4(1):73-92. PubMed ID: 22034240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal plasticity and survival in mood disorders.
    Duman RS; Malberg J; Nakagawa S; D'Sa C
    Biol Psychiatry; 2000 Oct; 48(8):732-9. PubMed ID: 11063970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulators of the glutamatergic system: implications for the development of improved therapeutics in mood disorders.
    Zarate CA; Quiroz J; Payne J; Manji HK
    Psychopharmacol Bull; 2002; 36(4):35-83. PubMed ID: 12858143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular and cellular theory of depression.
    Duman RS; Heninger GR; Nestler EJ
    Arch Gen Psychiatry; 1997 Jul; 54(7):597-606. PubMed ID: 9236543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic plasticity and mood disorders.
    Duman RS
    Mol Psychiatry; 2002; 7 Suppl 1():S29-34. PubMed ID: 11986993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate modulators as novel interventions for mood disorders.
    Mathew SJ; Keegan K; Smith L
    Braz J Psychiatry; 2005 Sep; 27(3):243-8. PubMed ID: 16224615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers.
    Manji HK; Chen G
    Mol Psychiatry; 2002; 7 Suppl 1():S46-56. PubMed ID: 11986995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression.
    Masi G; Brovedani P
    CNS Drugs; 2011 Nov; 25(11):913-31. PubMed ID: 22054117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant-like effects of 3,6'-disinapoyl sucrose on hippocampal neuronal plasticity and neurotrophic signal pathway in chronically mild stressed rats.
    Hu Y; Liao HB; Dai-Hong G; Liu P; Wang YY; Rahman K
    Neurochem Int; 2010 Feb; 56(3):461-5. PubMed ID: 20018220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New understanding of mechanisms of action of bipolar medications.
    Sanacora G
    J Clin Psychiatry; 2008; 69 Suppl 5():22-7. PubMed ID: 19265637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
    Machado-Vieira R
    J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal plasticity: a link between stress and mood disorders.
    Calabrese F; Molteni R; Racagni G; Riva MA
    Psychoneuroendocrinology; 2009 Dec; 34 Suppl 1():S208-16. PubMed ID: 19541429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressants and neuroplasticity.
    D'Sa C; Duman RS
    Bipolar Disord; 2002 Jun; 4(3):183-94. PubMed ID: 12180273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.